• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 16 of 19
Inside of a Gilead Sciences Lab
FinanceIsis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price
By Jen WiecznerDecember 18, 2015
Packs of Wrigley chewing gum are displayed in Westerville, O
TechDoublemint Gum Is an Awesome Biosensor
By Hilary BrueckDecember 3, 2015
MSMB Capital Management CIO Martin Shkreli
FinanceTuring CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
CNBC Events - Clinton Global Initiative 2015
TechA Theranos Deal With Safeway Stores May be Falling Apart
By Daniel RobertsNovember 11, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthAstrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
MSMB Capital Management CIO Martin Shkreli
HealthThis super-expensive drug is getting a $1 rival
By Benjamin SnyderOctober 23, 2015
Big pharma won’t stay silent in drug pricing debate for long
HealthBig pharma won’t stay silent in drug pricing debate for long
By Erika FryOctober 22, 2015
Biogen Idec Inc. CEO George Scangos Interview
HealthProfits up, Biogen cuts 11% of global workforce
By Erika FryOctober 21, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
CommentaryClinton’s big pharma takedown plan has some serious issues
By Chris Ford and Bethany CiancioloOctober 16, 2015
Theranos controversy has little to do with ‘unicorns’
TechTheranos controversy has little to do with ‘unicorns’
By Dan PrimackOctober 15, 2015
Monsanto slashing 2,600 jobs as corn sales slide
FinanceMonsanto slashing 2,600 jobs as corn sales slide
By Benjamin SnyderOctober 7, 2015
Symbolic - biotechnology - genetic engineering
HealthTPP trade deal: Even more bad news for biotech industry
By Laura LorenzettiOctober 5, 2015
Symbolic - biotechnology - genetic engineering
FinanceBiotech stock shock isn’t affecting startup deals or prices
By Dan PrimackOctober 2, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthBiotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
Biotech stocks fall into bear market territory
FinanceBiotech stocks fall into bear market territory
By Jen WiecznerSeptember 25, 2015
1...
  • 14
  • 15
  • 16
  • 17
  • 18
19
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointeeplaceholder alt text
By Eva RoytburgApril 29, 2026
Economy
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’placeholder alt text
By Eleanor PringleApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.